š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-08-19
Trial ID
NCT04892043
Treatments Being Tested
The primary goal of this phase I open label study is to determine the safet...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-09-14
Trial ID
NCT04131413
Treatments Being Tested
This phase ā ” clinical study was designed to evaluate the immunogenicity and...
Status
Unknown
Location
Multiple Locations
Start Date
2016-03-24
Trial ID
NCT02710851
The main purpose of this study was to evaluate the safety and reactogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-08-22
Trial ID
NCT05496231
Treatments Being Tested
This is a non-randomized, open label study to assess the reduction of Human...
Status
Recruiting
Location
Gynaecology Unit, Bellvitge University Hospital (HUB)
Start Date
2022-09-13
Trial ID
NCT05334706
Treatments Being Tested
This is a Phase 1/2, first-in-human, open label, multicenter study to asses...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2022-03-24
Trial ID
NCT05357898
Treatments Being Tested
To establish therapeutic dendritic cell (DC) vaccines targeting HPV 16/18 E...
Status
Unknown
Location
Shenzhen People's Hospital
Start Date
2019-04-01
Trial ID
NCT03870113
Treatments Being Tested
Aim: The main goal of this quantitative epidemiological observational study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-30
Trial ID
NCT06786429
Treatments Being Tested
This is an open-label exploratory clinical study. The main objective is to ...
Status
Unknown
Location
Heze Municipal Hospital
Start Date
2022-03-07
Trial ID
NCT05905354
Treatments Being Tested
This is a single-center, Phase II interventional study evaluating secondary...
Status
Recruiting
Location
Centre Oscar Lambret
Start Date
2025-01-13
Trial ID
NCT06658405
Treatments Being Tested